Related Drugs
Recombinant human interferon α1b injection
Indication: This product is suitable for the treatment of viral diseases and certain malignant tumors. It has been approved for the treatment of chronic hepatitis B, hepatitis C and hairy cell leukemia. There are clinical trial results or literature reports that it is effective in treating viral diseases such as herpes zoster, condyloma acuminatum, epidemic hemorrhagic fever and respiratory syncytial virus pneumonia in children. It can be used to treat malignant tumors such as chronic myeloid leukemia, melanoma, lymphoma, etc.
Manufacturer:
Beijing Tri-Prime Gene Pharmaceutical Co., Ltd.
Recombinant human interferon α1b injection
Indication: This product is suitable for the treatment of viral diseases and certain malignant tumors. It has been approved for the treatment of chronic hepatitis B, hepatitis C and hairy cell leukemia. There are clinical trial results or literature reports that it is effective in treating viral diseases such as herpes zoster, condyloma acuminatum, epidemic hemorrhagic fever and respiratory syncytial virus pneumonia in children. It can be used to treat malignant tumors such as chronic myeloid leukemia, melanoma, lymphoma, etc.
Recombinant human interferon α1b injection
Indication: This product is suitable for the treatment of viral diseases and certain malignant tumors. It is mainly used to treat chronic hepatitis B, chronic hepatitis C and hairy cell leukemia. It is effective for viral diseases such as condyloma acuminatum, chronic cervicitis, herpetic keratitis, herpes zoster, epidemic hemorrhagic fever and respiratory syncytial virus pneumonia in children. It also has good effects on other viral diseases and malignant tumors such as chronic myeloid leukemia, melanoma, lymphoma, etc.
Manufacturer:
Beijing Tri-Prime Gene Pharmaceutical Co., Ltd.
Recombinant human interferon α1b injection
Indication: This product is suitable for the treatment of viral diseases and certain malignant tumors. It is mainly used to treat chronic hepatitis B, chronic hepatitis C and hairy cell leukemia. It is effective for viral diseases such as condyloma acuminatum, chronic cervicitis, herpetic keratitis, herpes zoster, epidemic hemorrhagic fever and respiratory syncytial virus pneumonia in children. It also has good effects on other viral diseases and malignant tumors such as chronic myeloid leukemia, melanoma, lymphoma, etc.
Manufacturer:
Beijing Tri-Prime Gene Pharmaceutical Co., Ltd.
Recombinant human interferon α1b for injection
Indication: This product is suitable for the treatment of viral diseases and certain malignant tumors. It has been approved for the treatment of chronic hepatitis B, hepatitis C and hairy cell leukemia. There are clinical trial results or literature reports that it is effective in treating viral diseases such as herpes zoster, condyloma acuminatum, epidemic hemorrhagic fever and respiratory syncytial virus pneumonia in children. It can be used to treat malignant tumors such as chronic myeloid leukemia, melanoma, lymphoma, etc.
Ligustrazine Hydrochloride for Injection
Indication: 1. Cardiovascular diseases: hypertension, coronary heart disease, unstable angina, etc. 2. It has good curative effect on the acute stage, recovery stage and sequelae of ischemic cerebrovascular disease, such as cerebral insufficiency, cerebral thrombosis, cerebral embolism, cerebral arteriosclerosis, etc., and can improve the symptoms of hemiplegia, aphasia, dysphagia, limb numbness, weakness, headache, dizziness, insomnia, tinnitus, unsteady walking, memory loss, etc. caused by these diseases. 3. Respiratory system diseases: cor pulmonale, pulmonary hypertension, emphysema, pulmonary fibrosis, chronic respiratory failure, pediatric pneumonia, etc. 4. Others: vertigo, chronic renal failure, epidemic hemorrhagic fever, chronic active hepatitis, cervical spondylosis, sudden deafness, purpuric nephritis.
Manufacturer:
Beijing Sihuan Kebao Pharmaceutical Co., Ltd.
Ligustrazine Hydrochloride for Injection
Indication: 1. Cardiovascular diseases: hypertension, coronary heart disease, unstable angina, etc. 2. It has good curative effect on the acute stage, recovery stage and sequelae of ischemic cerebrovascular disease, such as cerebral insufficiency, cerebral thrombosis, cerebral embolism, cerebral arteriosclerosis, etc., and can improve the symptoms of hemiplegia, aphasia, dysphagia, limb numbness, weakness, headache, dizziness, insomnia, tinnitus, unsteady walking, memory loss, etc. caused by these diseases. 3. Respiratory system diseases: cor pulmonale, pulmonary hypertension, emphysema, pulmonary fibrosis, chronic respiratory failure, pediatric pneumonia, etc. 4. Others: vertigo, chronic renal failure, epidemic hemorrhagic fever, chronic active hepatitis, cervical spondylosis, sudden deafness, purpuric nephritis.
Manufacturer:
Harbin Medisan Pharmaceutical Co., Ltd.
Ligustrazine Hydrochloride for Injection
Indication: 1. Cardiovascular diseases: hypertension, coronary heart disease, unstable angina, etc. 2. It has good curative effect on the acute stage, recovery stage and sequelae of ischemic cerebrovascular disease, such as cerebral insufficiency, cerebral thrombosis, cerebral embolism, cerebral arteriosclerosis, etc., and can improve the symptoms of hemiplegia, aphasia, dysphagia, limb numbness, weakness, headache, dizziness, insomnia, tinnitus, unsteady walking, memory loss, etc. caused by these diseases. 3. Respiratory system diseases: cor pulmonale, pulmonary hypertension, emphysema, pulmonary fibrosis, chronic respiratory failure, pediatric pneumonia, etc. 4. Others: vertigo, chronic renal failure, epidemic hemorrhagic fever, chronic active hepatitis, cervical spondylosis, sudden deafness, purpuric nephritis.
Manufacturer:
Hefei Pingguang Pharmaceutical Co., Ltd.
Ligustrazine Hydrochloride for Injection
Indication: 1. Cardiovascular diseases: hypertension, coronary heart disease, unstable angina, etc. 2. It has good curative effect on the acute stage, recovery stage and sequelae of ischemic cerebrovascular disease, such as cerebral insufficiency, cerebral thrombosis, cerebral embolism, cerebral arteriosclerosis, etc., and can improve the symptoms of hemiplegia, aphasia, dysphagia, limb numbness, weakness, headache, dizziness, insomnia, tinnitus, unsteady walking, memory loss, etc. caused by these diseases. 3. Respiratory system diseases: cor pulmonale, pulmonary hypertension, emphysema, pulmonary fibrosis, chronic respiratory failure, pediatric pneumonia, etc. 4. Others: vertigo, chronic renal failure, epidemic hemorrhagic fever, chronic active hepatitis, cervical spondylosis, sudden deafness, purpuric nephritis.
Manufacturer:
Hefei Pingguang Pharmaceutical Co., Ltd.
Recombinant human interferon α1b for injection
Indication: This product is suitable for the treatment of viral diseases and certain malignant tumors. It has been approved for the treatment of chronic hepatitis B, hepatitis C and hairy cell leukemia. Clinical trial results and literature reports have shown that it is effective in treating viral diseases such as herpes zoster, condyloma acuminatum, epidemic hemorrhagic fever and respiratory syncytial virus pneumonia in children. It can be used to treat malignant tumors such as chronic myeloid leukemia, melanoma, lymphoma, etc.
Manufacturer:
Shenzhen Kexing Pharmaceutical Co., Ltd.